Esperion Therapeutics (NASDAQ:ESPR) Cut to Hold at StockNews.com
StockNews.com cut shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a buy rating to a hold rating in a research note released on Friday morning. Several other research firms have also weighed in on ESPR. Needham & Company LLC lowered their price objective on Esperion Therapeutics from $8.00 to $6.00 and set a buy […]
More Stories
Blake Lively Net Worth, Career, Family Life and More
Blake Ellender Brown Born on August 25, 1987, in the United States, Blake Ellender Lively is a famous actress. Lively...
North European Oil Royalty Trust (NYSE:NRT) Short Interest Update
North European Oil Royalty Trust (NYSE:NRT – Get Free Report) was the target of a significant drop in short interest...
Mapletree Industrial Trust (OTCMKTS:MAPIF) Sees Large Drop in Short Interest
Mapletree Industrial Trust (OTCMKTS:MAPIF – Get Free Report) was the recipient of a significant decrease in short interest during the...
Southwest Airlines Co. (NYSE:LUV) Sees Significant Drop in Short Interest
Southwest Airlines Co. (NYSE:LUV – Get Free Report) was the recipient of a large decline in short interest in the...
AGNC Investment Corp. (NASDAQ:AGNCO) Plans $0.41 Quarterly Dividend
AGNC Investment Corp. (NASDAQ:AGNCO – Get Free Report) announced a quarterly dividend on Friday, September 13th, NASDAQ reports. Shareholders of...
Agilent Technologies, Inc. (NYSE:A) Announces $0.24 Quarterly Dividend
Agilent Technologies, Inc. (NYSE:A – Get Free Report) declared a quarterly dividend on Wednesday, September 18th, NASDAQ reports. Investors of...